Colgate-Palmolive Q1 Results Review - Healthy Performance Across Portfolio; Upgrade To Reduce: Dolat Capital

Dolat Capital Report

Colgate-Palmolive India Ltd.’s Q1 FY25 revenue was ahead of our estimates. Domestic business revenue grew 13.1% YoY, led by high single-digit volume growth in toothpaste portfolio. Growth was supported by gradual demand recovery in rural markets.

Gross margin expanded 220 basis points YoY due to deflation in key raw material prices. Additionally, cost-saving initiatives led to Ebitda margin expansion of 240 bps despite higher investment in advertising.

As Q1 volume growth was a beat, we increase our FY25/26E earnings per share estimates by 2.2/4.4% at Rs 56.0/62.2. We upgrade our rating to ‘Reduce’ from Sell and value the stock at 52 times FY26E EPS (10% disc to HUL) to arrive at target price of Rs 3,232, led by improvement in company’s overall performance.

Click on the attachment to read the full report:

DISCLAIMER

This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.